![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/20/2901562/0/en/NephroDI-Therapeutics-Announces-Investment-by-Sound-Bioventures-to-Accelerate-Development-of-NDI-5001-as-a-Potential-First-in-Class-Therapy-for-Pediatric-Orphan-Kidney-Disease.html
https://www.pharmaceutical-technology.com/news/nephrodi-therapeutics-and-msrd-partner-to-develop-therapy-for-ndi/